Early versus late response to PD-1-based immunotherapy in metastatic melanomaGeorg Lodde, Selma Ugurel, Jochen Utikal et al.|European Journal of Cancer|2024Cited by 9
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusJan‐Malte Placke, Selma Ugurel, Luisa Sophie Rajcsanyi et al.|Frontiers in Immunology|2025Cited by 2